Synthetic Biology Market Segmentation, Parameters and Prospects 2023 to 2030 Industry Research Report
Synthetic
Biology Industry Overview
The global synthetic biology market size was valued at USD 13.09
billion in 2022 and is expected to expand at a compound annual growth rate
(CAGR) of 18.97% from 2023 to 2030.
The increasing scope of synthetic biology applications for
multiplexed diagnostics & cellular recording, as well as therapeutic genome
editing, is anticipated to surge its demand during the study period.
Additionally, the utility of organisms and products from synthetic biology
techniques in other sectors, including energy and chemicals, is also likely to
impact the overall market growth.
Gather more
insights about the market drivers, restrains and growth of the Synthetic Biology Market
The outbreak of COVID-19 led to an increased usage of synthetic
biology products in the past 2 years. Many key pharmaceutical and biotechnology
companies as well as synthetic biology players in the industry have increased
their research activities globally, by adopting new techniques for producing
test kits, therapies, and vaccines for COVID-19. In a study from European
Parliament, synthetic biology is considered to be one of the developing
technologies. It has the ability to be used in combating COVID-19 infection.
Synthetic biology has also been highlighted as a means to accelerate vaccine
development by the National Institute of Health in the U.S.
The global market is expected to advance as a result of the
growing research and development activities in various fields. To improve
conventional biofuel production, players are implementing synthetic biology
approaches to enhance performance and increase the utilization of low-cost
inputs such as waste. For instance, fashion companies such as Modern Meadow,
Bolt Threads, and Vitro Labs are employing biotechnology to develop sustainable
materials.
The market witnessed strong investments from private & public
partnerships. As per the data published by SynBioBeta, the startups in the synthetic
biology industry raised 7.8 billion in investment in 2020, and USD 18.0 billion
in 2021. Companies such as Arbor Biotechnologies and DNA Script raised around
USD 215 million and USD 167.2 million, respectively. The heavy investment
increases the circulation of funds in the market and supports the growth of
companies across the supply chain.
Furthermore, advances in genome editing and the presence of
bio-foundries, as well as the availability of natural resources and enormous
markets, are highlighted as global strengths in synthetic biology to build a
bio-based economy. The possible challenges to the field's long-term
development, such as insufficient infrastructure and policies, are discussed
along with proposals for overcoming them through public-private partnerships,
more effective multilateral cooperation, and a well-developed governance
framework.
Additionally, players in the market are entering with the latest
technologies in order to meet the growing demand and capture untapped avenues
of the market. For instance, in November 2021, Creative Biogene released its
broad shRNA products to accelerate RNAi research. The company has broad
expertise and experience to offer high-quality RNAi products, including shRNA
clones and siRNA libraries, intending to provide effective, convenient, and
reliable tools to fast-track RNAi research.
Browse
through Grand View Research's Biotechnology Industry Research Reports.
• The global recombinant
DNA technology market size was valued at USD 728.9 billion in 2023 and is projected to
grow at a CAGR of 5.4% from 2024 to 2030.
• The global DNA
diagnostics market size was estimated at USD 10.64 billion in 2023 and is projected
to grow at a CAGR of 4.51% from 2024 to 2030.
Global
Synthetic Biology Market Segmentation
This report forecasts revenue growth at the global, regional, and
country levels and provides an analysis of the latest trends in each of the
sub-segments from 2018 to 2030. For this study, Grand View Research has
segmented the global synthetic biology market report based on technology,
product, application, end-use, and region:
Technology
Outlook (Revenue, USD Million, 2018 - 2030)
·
NGS Technology
·
PCR Technology
·
Genome Editing Technology
·
Bioprocessing Technology
·
Other Technologies
Product
Outlook (Revenue, USD Million, 2018 - 2030)
·
Oligonucleotide/Oligo Pools and Synthetic DNA
·
Enzymes
·
Cloning Technologies Kits
·
Xeno-Nucleic Acids
·
Chassis Organism
Application
Outlook (Revenue, USD Million, 2018 - 2030)
·
Healthcare
o
Clinical
o
Non-Clinical
·
Non-healthcare
o
Biotech Crops
o
Specialty Chemicals
o
Bio-fuels
o
Others
End-use
Outlook (Revenue, USD Million, 2018 - 2030)
·
Biotechnology and Pharmaceutical Companies
·
Academic and Government Research Institutes
·
Others
Regional
Outlook (Revenue, USD Million, 2018 - 2030)
·
North America
o
US
o
Canada
·
Europe
o
UK
o
Germany
o
France
o
Italy
o
Spain
o
Russia
·
Asia Pacific
o
Japan
o
China
o
India
o
Australia
o
Singapore
·
Latin America
o
Brazil
o
Mexico
·
Middle East & Africa
o
South Africa
o
Saudi Arabia
o
UAE
Key Companies
& Market Share Insights
Key players in this market are implementing various strategies to
increase profitability, including partnerships, mergers & acquisitions,
geographical expansions, and strategic collaborations. For instance, in July
2021, Codexis, Inc. and Kalsec, Inc. announced the expansion of their research
collaboration and enrolled in a special supply agreement for a new enzyme to
manufacture Kalsec’s newest natural hop acid. Some prominent players in the
global synthetic biology market include.
·
Bota Biosciences Inc.
·
Codexis, Inc.
·
Creative Biogene.
·
Creative Enzymes.
·
Enbiotix, Inc.
·
Illumina, Inc.
·
Merck Kgaa (Sigma-Aldrich Co. Llc)
·
New England Biolabs
·
Euro fins Scientific
·
Novozymes
·
Pareto Bio, Inc.
·
Scarab Genomics, Llc
·
Synthego
·
Synthetic Genomics Inc.
·
Thermo Fisher Scientific, Inc.
Order a free sample PDF of the Synthetic
Biology Market Intelligence Study, published by Grand View Research.
Comments
Post a Comment